Company intelligence / Profile preview

Rosa Biotech

Bristol, England, United Kingdomrosabionaturalcosmetics.com ↗

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

Rosa Biotech developed a novel AI-driven biosensing platform for early disease diagnosis and industrial biotechnology applications. The company leveraged protein design innovations from academic research and machine learning to discriminate between complex biological samples. No clinical trial results are available as the focus was on diagnostics/platform rather than therapeutics.

Therapeutic areas: Other
Modalities: Diagnostic platform (biosensing)Machine learning-based biosensing technology
Industry: Protein Biomarker Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Rosa Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosa Biotech.

Explore the full profile